Immune responses in hepatitis C virus infection

Journal of Hepatology, Supplement

Volumn 24, Issue 2, 1996, Pages 20-25

  Spengler, Ulrich ^a   Lechmann, Martin ^a   Irrgang, Bettina ^a   Dumoulin, Franz Ludwig ^a   Sauerbruch, Tilman ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

CD4+ lymphocytes; Hepatitis C virus; Immune responses; Pathogenesis

Indexed keywords

CORE PROTEIN; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS PROTEIN;

ANTIBODY PRODUCTION; B LYMPHOCYTE; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; HEPATITIS C; HEPATITIS C VIRUS; HISTOCOMPATIBILITY COMPLEX; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; REINFECTION; VIRUS CELL INTERACTION; VIRUS PATHOGENESIS;

CD4-POSITIVE T-LYMPHOCYTES; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0029817307     PISSN: 01695185     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (41)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley D\V, Houghton M. Isolation of a cDNA clone derived from a blood borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-62.
2. Seeff LB, Buskell-Bales Z, Wright EC, Durako SJ, Alter HJ, Iber FL, Hollinger FB, Gitnick G, Knodell RG, Perillo RP, Stevens CE, Hollingsworth CG, and the National Heart, Lung and Blood Institute Study Group. Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl JMed 1992; 327: 1906-11.
3. Eyster ME, Diamondstone LS, Lien JM, Ehmann WC, Quan S, Goedert JJ for the Multicenter Hemophilia Cohort.Study. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: Effect of coinfection with human immunodeficiency virus. J Aqu Immunodef Synd 1993; 6: 602-10.
4. Lim HL, Lau GKK, Davis GL, Dolson pj, Lau JYN. Cholestatic hepatitis leading to hepatic failure in a patient with organ-transmitted hepatitis C virus infection. Gastroenterology 1994; 106: 248-51.
5. Bjoro K, Froland SS, Yun Z, Samdal HH, Haaland T. Hepatitis C in primary hypogammaglobulinemia. J Hepatol 1994; Suppl 1: 21: S25 (Abstr).
6. Jacobson S, Kichert JR, Biddison WE, Satinsky A, Harztmann RJ, Me Farland HF. Measles virus specific T4+ human cytotoxic T cell clones are restricted by class II HLA antigens. J Immunol 1984; 133: 754-7.
7. Fleischer B, Brecht H, Rott R. Recognition of viral antigens by human influenza A virus-specific T lymphocyte clones. J Immunol 1985; 135: 2800-5.
8. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lyrnphokine activities and secreted proteins. J Immunol 1986; 136: 2348-57.
9. Yatsuhashi H, Inokuchi K, Inoue O, et al. The clinical significance of reactivity to individual epitopes of the hepatitis C viral genome. Gastroenterol Jpn 1993; Suppl 5: 28: 6-11.
10. Simmonds P, Rose KA, Graham S, Chan SW, McOmish F, Dow BC, Follet EAC, Yap PL, Marsden H. Mapping of serotype-specific, immunodominant epitopes in the NS4 region of hepatitis C virus (HCV): Use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, 3. J Clin Microbiol 1993; 31: 1493-503.
11. Nagayama R, Miyake K, Tsuda F, Okamoto H. IgM antibody to a hepatitis C virus core peptide (CP14) for monitoring activity of liver disease in patients with acute or chronic hepatitis C. J Med Virol 1994; 42: 311-7.
12. Ray R, Khanna A, Lagging ML et al. Peptide immunogen mimicry of putative El glycoprotein-specific epitopes in hepatitis C virus. J Virol 1994; 68: 4420-6.
13. Chien DY, Choo QL, Ralston R, et al. Persistence of HCV despite antibodies to both putative envelope glycoproteins. Lancet 1993; 342: 933.
14. Lesniewski RR, Boardway KM, Casey JM, et al. Hypervariable 5'-terminus of hepatitis C virus E2/NS1 encodes antigenically distinct variants. J Med Virol 1993; 40: 150-6.
15. Kato N, Sekiya H, Ootsuyama Y, et al. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J Virol 1993; 67: 3923-30.
16. Weiner AJ, Geysen HM, Christopherson C, Hall JE, Mason TJ, Saracco G, Bonino F, Crawford KA, Brunetto M, Barr PJ, Miyamura T, McHutchinson J, Houghton M. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: Potential role in chronic HCV infections. Proc Natl Acad Sci USA 1992; 89: 3468-72.
17. Kumar U, Monjardino J, Thomas H. Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an asammaglobulinemic patient. Gastroenterology 1994; 106: 1072-5.
18. Yamaguchi K, Tanaka E, Higashi K, et al. Adaptation of hepatitis C virus for persistent infection in patients with acute hepatitis. Gastroenterology 1994; 106: 1344-8.
19. Farci P, Alter HT, Govindarajan S, Wong DC, Engle R, Lesniewski RR, Mushahwar IK, Lu Desai SM, Miller RH, Ogata N, Purcell RH. Lack of protective immunity against reinfection with hepatitis C virus. Science 1992; 258: 13540.
20. Van Doom JL, Quint W, Tsiquaye K, et al. Longitudinal analysis of hepatitis C virus infection and genetic drift of the hypervariable region. J Infect Dis 1994; 169: 1226-35.
21. Pozzato G, Moretti M. Lymphocyte subsets in HCV-positive chronic liver disease. Immunol Today 1994; 15: 137-8.
22. Jarvis JN, Kaplan J, Fine N. Increase in CD5+ B-cells in juvenile rheumatoid arthritis - Relationship to IgM rheumatoid factor expression and disease activity. Arthitis Rheum 1992; 35: 204.
23. Hartmann H, Schott P, Polzien F, Kaboth U, Ramadori G. Kryoglobulinämie bei chronischer Hepatitis C-Virus-Infektion: Prävalenz, klinische Befunde und Analyse der Kryopräzipitate. Z Gastroenterol 1995; 33: 77 (Abstr).
24. Gotch F, Rothbard J, Howland K, Townsend A, McMichael A. Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2. Nature 1987; 326: 881-2.
25. Shirai M, Akatsuka T, Pendleton CD, Houghton R, Wichowski C, Mihalik K, Feinstone S. Induction of cytotoxic T cells to a cross-reactive hepatitis C virus non-structural RNA polymerase-like protein. J Virol 1992; 66: 4098-106.
26. Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R, Walker BD. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 1992; 149: 3339-44.
27. Erickson AL, Houghton M, Choo QL, Weiner AJ, Ralston R, Muchmore E, Walker CM. Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C. J Immunol 1993; 151: 4189-99.
28. Kita H, Moriyama T, Kaneko T, Harase I, Nomura M, Miura H, Nakamura I, Yazaki Y, Imawari M. HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein. Hepatology 1993; 18: 103914.
29. Koziel MJ, Dudley D, Afdahl N, Choo Q-L, Houghton M, Ralston R, Walker BD. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol 1993; 67: 752-32.
30. Shirai M, Okada H, Nishioka M, Akatsuka T, Wychowski C, Houghton R, Pendleton CD, Feinstone SM, Berzofsky JA. An epitope in hepatitis core region recognized by cytotoxic T cells in mice and humans. J Virol 1994; 68: 3334-42.
31. Cerny A, Chisari FV. Immunological aspects of HCV infection. Interviroloy 1994; 37: 119-25.
32. Cerny A, McHutchinson JG, Pasqinelli C, Brown ME, Brothers MA, Grabscheid B, Fowler P, Houghton M, Chisari FV. Cytotoxic T lymphocyte response to hepatitis C virusderived peptides containing the HLA A2.1 binding motif. J Clin Invest 1995; 95: 521-30.
33. Phillips RE, Rowland-Jones S, Nixon DF, Gotch FM, Edwards JP, Ogunlesi AO, Rothbard JA, Bangham CRM, Rizza CR, McMichael AJ. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 1991; 354: 453-9.
34. Botarelli P, Brunette MR, Minutello MA, Calvo P, Unutmaz D, Weiner AJ, Choo QL, Shuster JR, Kuo G, Bonino F, Houghton M, Abrigani S. T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology 1993; 104: 580-7.
35. Ferrari C, Valli A, Galati L, Penna A, Scaccaglia P, Giuberti T, Schianchi C, Missale G, Marin MG, Ficcadori F. T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology 1994; 19: 286-95.
36. Lechmann M, Ihlenfeldt HG, Braunschweiger I, Giers G, Jung G, Matz B, Kaiser R, Sauerbruch T, Spengler U. T and B cell responses to different hepatitis C virus antigens in patients with chronic hepatitis and healthy seropositives. 1995, submitted.
37. Minutello MA, Pileri P, Unutmaz D, Censini S, Kuo G, Houghton M, Brunetto MR, Bonino F, Abrigani S. Compartmentalization of T lymphocytes to the site of disease: Intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J Exp Med 1993; 178: 17-25.
38. Irrgang B, Lechmann M, Ihlenfeldt HG, Giers G, Johnson JP, Jung G, Sauerbruch T, Spengler U. Identification of potentially antagonistic peptide epitopes of the hepatitis C core protein. Hepatology 1994; 20: 229A (Abstr).
39. Clerici M, Shearer GM. A TH1-TH2 switch is a critical step in the etiology of HIV infection. Immunology Today 1993; 14: 107-11.
40. Bouffard P, Hayashi PH, Acevedo R, Levy N, Zeldis JB. Hepatitis C virus is detected in a monocyte/macrophage subpopulation of peripheral blood mononuclear cells of infected patients. J Infect Dis 1992; 166: 1276-80.
41. Gooding LR. Virus proteins that counteract host immune defenses. Cell 1992; 71: 5-7.